Literature DB >> 15465082

High frequency of allergic conjunctivitis in myasthenia gravis without thymoma.

Hiroyuki Murai1, Manabu Osoegawa, Hirofumi Ochi, Jun-Ichi Kira.   

Abstract

OBJECTIVES: To investigate the frequency of allergic disorders in myasthenia gravis (MG) patients and characterize the features of MG associated with allergic disorders.
METHODS: Frequencies of past and present common allergic disorders in 160 MG patients who visited the Department of Neurology, Kyushu University Hospital from April 2000 to July 2003 and in 81 neurological normal controls were studied.
RESULTS: Among various allergic disorders, the frequency of allergic conjunctivitis (AC) was significantly higher in MG patients (39/160, 24.4%, p(corr)=0.0112), especially with MG without thymoma (36/123, 29.3%, p(corr)=0.0016), in comparison to the controls (6/81, 7.4%). MG patients with AC showed a significantly higher rate of seronegative MG (43.6% vs. 17.4%, p=0.008) and a higher tendency of ocular MG (43.6% vs. 28.1%, p=0.071). Moreover, MG with AC had significantly lower anti-acetylcholine receptor antibody titers (median 6.8 nmol/l vs. median 23.6 nmol/l, p=0.0359) as well as a lower rate of coexisting thymoma (7.7% vs. 17.4%, p=0.016). The incidence of myasthenic crisis was also lower in MG with AC than without AC, yet the difference was not significant (7.7% vs. 15.7%).
CONCLUSION: There was a significant association of AC with MG especially for ocular or seronegative MG in cases without thymoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465082     DOI: 10.1016/j.jns.2004.06.018

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  1 in total

1.  Higher risk of myasthenia gravis in patients with thyroid and allergic diseases: a national population-based study.

Authors:  Jiann-Horng Yeh; Huang-Tsung Kuo; Hsuan-Ju Chen; Yen-Kung Chen; Hou-Chang Chiu; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.